Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-06-21 Purchase | 2021-06-22 5:09 pm | Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer | 1,000 | $6.81 | $6,810 | 36,510 (Direct) | View |
| 2020-10-01 Purchase(A) | 2020-10-05 5:33 pm | Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer | 6,000 | $4 | $24,000 | 47,248 (Direct) | View |
| 2020-10-01 Purchase | 2020-10-05 4:43 pm | Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer | 6,000 | $2.1 | $12,600 | 47,248 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-01 Tax Withholding | 2024-04-12 4:57 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer | 518 | $2.79 | 30,157 (Direct) | View |
| 2024-01-01 Exercise | 2024-04-12 4:57 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer | 1,675 | $0 | 30,157 (Direct) | View |
| 2023-10-12 Option Award | 2023-10-12 5:58 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer | 15,000 | $0.33 | 99,250 (Direct) | View |
| 2023-10-10 Option Award | 2023-10-10 4:51 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer | 22,500 | $0.24 | 84,250 (Direct) | View |
| 2023-02-09 Option Award | 2023-02-10 5:20 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer | 12,500 | $0.8 | 61,750 (Direct) | View |
| 2022-12-31 Option Award | 2023-01-04 5:42 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer | 178,768 | $0 | 1,293,326 (Direct) | View |
| 2022-09-30 Option Award(A) | 2022-10-05 4:40 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer | 12,950 | $0 | 339,663 (Direct) | View |
| 2022-06-30 Option Award | 2022-10-03 4:51 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer | 23,947 | $0 | 326,713 (Direct) | View |
| 2022-08-05 Exercise | 2022-08-09 4:28 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer | 7,601 | $0 | 49,250 (Direct) | View |
| 2022-08-05 Tax Withholding | 2022-08-09 4:28 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer | 2,462 | $3.17 | 49,250 (Direct) | View |
| 2022-06-30 Option Award | 2022-07-05 5:35 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer | 23,947 | $0 | 326,713 (Direct) | View |
| 2022-04-01 Option Award | 2022-04-11 5:54 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer | 247,841 | $0 | 302,766 (Direct) | View |
| 2021-11-01 Option Award | 2022-04-04 5:46 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer | 15,001 | $0 | 64,847 (Direct) | View |
| 2021-12-31 Option Award(A) | 2022-01-06 5:21 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer | 6,722 | $0 | 22,780 (Direct) | View |
| 2021-09-30 Option Award(A) | 2022-01-06 4:07 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer | 6,024 | $0 | 16,058 (Direct) | View |
| 2021-12-31 Option Award | 2022-01-04 5:27 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer | 6,722 | $0 | 6,722 (Direct) | View |
| 2021-09-30 Option Award | 2021-10-04 4:38 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer | 6,024 | $0 | 6,024 (Direct) | View |
| 2021-08-05 Option Award | 2021-08-09 4:38 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer | 7,601 | $0 | 44,111 (Direct) | View |
| 2021-07-08 Option Award | 2021-07-09 4:31 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer | 23,337 | $0 | 31,464 (Direct) | View |
| 2021-06-08 Option Award | 2021-06-10 5:06 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer | 8,127 | $0 | 8,127 (Direct) | View |
Ownership | 2020-10-02 4:46 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer | 0 | $0 | 105,543 (Direct) | View |
| 2019-06-11 Option Award | 2019-06-12 4:23 pm | N/A N/A | GSE SYSTEMS INC | GVP | Stanker James H Director | 25,316 | $0 | 48,118 (Direct) | View |